Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 37 clinical trials
Biological Collection and Registry of Patients Who Will Have a TAVR (Transcatheter Aortic Valve Replacement) Intervention

A sample of plasma and whole blood will be obtained at 4 time points (pre-procedural, early post-procedural, at hospital discharge and during an eventual visite at 3 or 6 months post-procedural). Test for platelet reactivity (LTA, light transmittance aggregometry and Elisa PRI, Platelet reactivity index), multimeric VWF (von Willebrand factor) …

aortic valve replacement
  • 1 views
  • 22 Jan, 2021
Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over

The aim of the study is to compare, in real life, the risk benefit (including both major bleeding and thrombotic events (TE) and death from any cause) associated with direct oral anticoagulants (DOA) and with anti vitamin K (VKA) in older adults ( 80 years) suffering from non valvular atrial …

dabigatran
apixaban
warfarin
anticoagulants
rivaroxaban
  • 3 views
  • 23 Jan, 2021
  • 2 locations
Perioperative Anticoagulant Use for Surgery Evaluation Emergency Registry

Among patients who are receiving long-term anticoagulant therapy, whether with a direct oral anticoagulant (DOAC) or vitamin K antagonist (VKA), approximately 3-5% who require treatment

vascular disease
edoxaban
anticoagulant therapy
stroke
dabigatran
  • 5 views
  • 23 Jan, 2021
  • 3 locations
Oral Anti-coagulants in Fragile Patients With Percutaneous Endoscopic Gastrostomy and Atrial Fibrillation (ORIGAMI) Pilot Study

practical guide on the use of non-vitamin K antagonist oral anticoagulants stated that "data have shown that administration in a crushed form (e.g. via a nasogastric tube), does not alter the

edoxaban
anticoagulant therapy
apixaban
anticoagulation therapy
anticoagulants
  • 6 views
  • 26 Jan, 2021
  • 1 location
Registry of Patient With Antithrombotic Agents Admitted to an Emergency Department

Antithrombotics with antiplatelet agents, vitamin K antagonist (VKA), heparin and related substances, and new oral anticoagulants are prescribed for arterial diseases, especially in secondary

  • 0 views
  • 21 Jan, 2021
PIVKA-II Combined With Alpha-Fetoprotein for Diagnostic and Prognostic Value of Hepatic Tumors in Infants

Although hepatic tumors are uncommon in the perinatal period they are associated with significant morbidity and mortality in affected patients. The study is intended to evaluate the diagnostic efficiency of Protein Induced by Vitamin K Absence or antagonist-II(PIVKA-II) combining with alpha-fetoprotein in hepatic tumor of infant. This study is a …

liver tumor
pivka-ii
tumor markers
  • 0 views
  • 24 Jan, 2021
  • 1 location
Management of Atrial Fibrillation in Patients With Cancer (MAFIC Study)

The primary objective is to assess the safety and efficacy of switching from direct oral anticoagulants to low molecular weight heparin in cancer patients during antineoplastic therapy

edoxaban
fibrillation
stroke
dabigatran
apixaban
  • 20 views
  • 25 Jan, 2021
  • 2 locations